As Russia’s clinical trials sector falls, Ukraine rebuilds
We analyse the impact of the war on the clinical trial landscapes of Ukraine and Russia, as local investigators chronicle the situation on the ground.
Special Focus
AIM ImmunoTech outlines Phase II study plans for long Covid fatigue
Ascletis receives FDA nod for Phase Ib Covid-19 oral drug trial
DCRI tasked as data centre for NIH long Covid studies
Axcella previews long Covid registrational trial plans in UK and US
AIM ImmunoTech reports positive Phase III Ampligen data in long Covid
Pfizer, BioNTech begin Phase II trial of ‘enhanced’ Covid-19 vaccine
Humanigen’s lenzilumab fails in ACTIV study recruiting hospitalised Covid-19 patients
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
